RESUMO
La diabetes mellitus tipo 1 (DM1) es una enfermedad crónica autoinmune, con una incidencia creciente a nivel mundial. Los avances en el diagnóstico y en el tratamiento de los últimos años prolongaron la esperanza de vida, aumentando así el número de adultos con DM1. Se realizó un corte transversal que incluyó 201 personas adultas con diagnóstico de DM1, afiliados activos a la prepaga institucional de un hospital de alta complejidad de Argentina a Marzo de 2020. Se consignaron las siguientes variables: edad, sexo, comorbilidades, presencia de complicaciones, control glucémico y tratamiento farmacológico. Hubo un porcentaje similar de hombres y mujeres (51,2%), con una mediana de edad de 45 años (IIC 31-59). Un tercio de la población era mayor de 65 años. La mediana de evolución desde el diagnóstico fue de 14,5 años, y la mediana de último valor de hemoglobina glicosilada fue de 7,9%. Entre las complicaciones microvasculares más frecuentes se mencionan pie diabético (18%), retinopatía (6%) y nefropatía (2%). Un 4% presentó enfermedad cardiovascular (infarto agudo de miocardio, enfermedad coronaria, accidente cerebrovascular y/o enfermedad vascular periférica). El 88% recibía tratamiento con esquema intensificado de insulina y 6% usaban infusores de insulina. En relación al tratamiento con antidiabéticos orales, solo 11% recibían metformina, mientras que el uso de otros antidiabéticos orales fue inferior al 4%. En conclusión, este estudio proporciona valiosa información sobre las características de los adultos con DM1, dado que no hay demasiados estudios que aborden esta población (AU)
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease, with an increasing incidence worldwide. Advances in diagnosis and treatment in recent years have extended life expectancy, thus increasing the number of adults with T1DM. A cross-sectional study was conducted, including 201 adult individuals diagnosed with T1DM, active members of the institutional health plan of a high-complexity hospital in Argentina as of March 2020. The following variables were recorded: age, gender, comorbidities, presence of complications, glycemic control, and pharmacological treatment. There was a similar percentage of men and women (51.2%), with a median age of 45 years (IQR 31-59). One-third of the population was over 65 years old. The median duration since diagnosis was 14.5 years, and the median of the last glycated hemoglobin value was 7.9%. Among the most frequent microvascular complications, diabetic foot (18%), retinopathy (6%), and nephropathy (2%) were mentioned. 4% had cardiovascular disease (acute myocardial infarction, coronary artery disease, stroke, and/or peripheral vascular disease). 88% received treatment with intensified insulin regimens, and 6% used insulin pumps. Regarding treatment with oral antidiabetic drugs, only 11% received metformin, while the use of other oral antidiabetic drugs was less than 4%. In conclusion, this study provides valuable information about the characteristics of adults with T1DM, as there are not many studies that address this population (AU)
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Diabetes Mellitus Tipo 1/complicações , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/terapia , Estudos Transversais , Assistência HospitalarRESUMO
This report presents the various cholera case definitions used by the affected countries of Latin America, shows the numbers of cholera cases and deaths attributable to cholera (as reported by Latin American countries to PAHO through 1993), and describes some regional trends in cholera incidence. The information about how cholera cases were defined was obtained from an October 1993 PAHO questionnaire. In all, 948 429 cholera cases were reported to PAHO by affected Latin American countries from January 1991 through December 1993, the highest annual incidences being registered in Peru (1991 and 1992) and Guatemala (1993). The case-fatality rate over the three-year period, and also in 1993, was 0.8%. A general downward trend in the incidence of cholera was observed in most South American countries, while the incidence increased in most Central American countries. A good deal of variation was noted in the definitions used for reporting cholera cases, hospitalized cholera cases, and cholera-attributable deaths. Because of these variations, broad intercountry comparisons (including disease burden calculations and care quality assessments based on case-fatality rates) are difficult to make, and even reported trends within a single country need to be evaluated with care. The situation is likely to be complicated in the future by the arrival of V. cholerae 0139 in Latin America, creating a need to distinguish between it and the prevailing 01 strain. For purposes of simplicity, wide acceptance, and broad dissemination of case data, the following definitions are recommended: Confirmed case of 01 cholera: laboratory-confirmed infection with toxigenic V. cholerae 01 in any person who has diarrhea. Confirmed case of 0139 cholera: laboratory-confirmed infection with toxigenic V. cholerae 0139 in any person who has diarrhea. Clinical case of cholera: acute watery diarrhea in a person over 5 years old who is seeking treatment. Death attributable to cholera: death within one week of the onset of diarrhea in a person with confirmed or clinically defined cholera. Hospitalized patient with cholera: a person who has confirmed or clinically defined cholera and who remains at least 12 hours in a health care facility for treatment of the disease
En este informe se presentan las diversas definiciones de casos de cólera usadas en los países de América Latina que se han visto afectados por la epidemia; se da el número de casos de cólera y de las defunciones por la enfermedad (según datos notificados a la OPS por los países latinoamericanos en 1993), y se describen algunas tendencias regionales de la incidencia de cólera. La información relacionada con la forma en que se definieron los casos de la enfermedad se obtuvo por medio de un cuestionario administrado por la OPS en octubre de 1993. En total, 948 429 casos de cólera fueron notificados a la OPS entre enero de 1991 y diciembre de 1993 por los países latinoamericanos afectados por la epidemia y las incidencias anuales más altas se registraron en el Perú (1991 y 1992) y Guatemala (1993). La tasa de letalidad para todo el trienio, y también para 1993, fue de 0,8%. La incidencia de cólera mostró una tendencia descendente general en la mayor parte de los países sudamericanos pero aumentó en casi todos los países de Centroamérica. Se observó gran variabilidad en las definiciones aplicadas para notificar casos de cólera, casos de cólera hospitalizados y defunciones atribuibles al cólera. Esta variabilidad dificulta cualquier comparación global entre países (y hasta estimar la carga de morbilidad y evaluar la calidad de la atención sobre la base de las tasas de letalidad), y aun las tendencias notificadas dentro de un mismo país deben evaluarse con cuidado. Es muy probable que en un futuro la situación se complique por la llegada de la cepa Vibrio cholerae 0139 a América Latina, situación que genera la necesidad de distinguir entre ella y la cepa 01, que es la predominante. Para efectos de simplificación y para lograr la amplia aceptación y extensa divulgación de la información sobre los casos, se recomiendan las siguientes definiciones: caso confirmado de cólera 01: infección por V. cholerae 01 toxígeno, confirmada por métodos de laboratorio, en cualquier persona con diarrea. Caso confirmado de cólera 0139: infección confirmada por V. cholerae 0139 toxígeno, confirmada por un laboratorio, en cualquier persona con diarrea. Caso clínico de cólera: diarrea acuosa de carácter agudo en una persona mayor de 5 años que busca tratamiento. Defunción atribuible al cólera: defunción durante la semana inmediatamente posterior al comienzo de la diarrea en una persona con cólera confirmado o diagnosticado según la definición clínica. Paciente hospitalizado con cólera: persona con cólera confirmado o diagnosticado según la definición clínica que pasa un mínimo de 12 horas en un centro de atención para el tratamiento de la enfermedad.
Assuntos
Surtos de Doenças , Cólera/epidemiologia , Estudos de Coortes , América Latina/epidemiologia , Cólera/mortalidade , Monitoramento EpidemiológicoAssuntos
Cólera , Monitoramento Epidemiológico , América Latina , Surtos de Doenças , Estudos de CoortesRESUMO
This report presents the various cholera case definitions used by the affected countries of Latin America, shows the numbers of cholera cases and deaths attributable to cholera (as reported by Latin American countries to PAHO through 1993), describes some regional trends in cholera incidence. The information about how cholera cases were defined was obtained from an Octuber 1993 PAHO questionnarie. In all, 948 429 cholera cases were reported to PAHO by affected Latin America countries from January 1991 through December 1993, the highest annual incidences being registered in Peru (1991 and 1992) and Guatemala (1993). The case-fatality rate over the three-year period, and also in 1993, was 0.8 per cent. A general downward trend in the incidence of cholera was observed in most South American countries, while the incidence increased in most Central American countries. A good deal of variation was noted in the definitions used for reporting cholera cases, hospitalized cholera cases, and cholera-attributable deaths. Because of these variations broad intercountry comparisons (including disease burden calculations and care quality assessments base on case-fatality rates) are difficult to make, and even reported trends within a single country need to be evaluated with care. The situation is likely to be complicated in the future by the arrival of V. cholerae O139 in Latin America, creating a need to distinguish between it and the prevailing O1 strain. For purposes of simplicity, wide acceptance, and broad dissemination of case data, the following definitions are recommended: Confirmed case of O1 cholera: laboratory-confirmed infection with toxigenic V. cholerae O1 in any person who has diarrhea. Confirmed case of O139 cholera: laboratory-confirmed infection with toxigenic V. cholerae 0139 in any person who has diarrhea. Clinical case of cholera: acute watery diarrhea in a person over 5 years old who is seeking treatment. Death attributable to cholera: death within one week of the onset of diarrhea in a person with confirmed or clinically defined cholera. Hospitalized patient with colera: a person who has confirmed or clinically defined cholera and who remains at last 12 hours in a health care facility for treatment of the disease
This report will also be published in Spanish in the Bol. Oficina Sanit. Panam. Vol. 121, 1996